Onward Medical 将来の成長
Future 基準チェック /26
Onward Medical's earnings are forecast to decline at 1.3% per annum while its annual revenue is expected to grow at 113.9% per year. EPS is expected to grow by 8.2% per annum.
主要情報
-1.3%
収益成長率
8.2%
EPS成長率
| Medical Equipment 収益成長 | 15.7% |
| 収益成長率 | 113.9% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | 29 Oct 2024 |
今後の成長に関する最新情報
更新なし
Recent updates
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 39 | -33 | -34 | -31 | 3 |
| 12/31/2025 | 10 | -44 | -38 | -43 | 4 |
| 12/31/2024 | 2 | -36 | -34 | -36 | 4 |
| 6/30/2024 | 0 | -35 | -29 | -29 | N/A |
| 3/31/2024 | 0 | -36 | -31 | -30 | N/A |
| 12/31/2023 | 1 | -36 | -33 | -32 | N/A |
| 9/30/2023 | 1 | -36 | -33 | -33 | N/A |
| 6/30/2023 | 2 | -36 | -33 | -33 | N/A |
| 3/31/2023 | 2 | -34 | -30 | -30 | N/A |
| 12/31/2022 | 2 | -33 | -27 | -27 | N/A |
| 9/30/2022 | 2 | -35 | -27 | -26 | N/A |
| 6/30/2022 | 2 | -38 | -27 | -25 | N/A |
| 3/31/2022 | 2 | -36 | -25 | -22 | N/A |
| 12/31/2021 | 1 | -34 | -22 | -20 | N/A |
| 9/30/2021 | 1 | -29 | -18 | -17 | N/A |
| 6/30/2021 | 1 | -24 | -14 | -14 | N/A |
| 3/31/2021 | 1 | -22 | -13 | -13 | N/A |
| 12/31/2020 | 1 | -20 | -13 | -13 | N/A |
| 12/31/2019 | 1 | -13 | -10 | -10 | N/A |
| 12/31/2018 | 0 | -10 | -7 | -7 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: 63E is forecast to remain unprofitable over the next 3 years.
収益対市場: 63E is forecast to remain unprofitable over the next 3 years.
高成長収益: 63E is forecast to remain unprofitable over the next 3 years.
収益対市場: 63E's revenue (113.9% per year) is forecast to grow faster than the German market (5.5% per year).
高い収益成長: 63E's revenue (113.9% per year) is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if 63E's Return on Equity is forecast to be high in 3 years time